Anita Kumar

Also affiliated with Memorial Sloan Kettering Cancer Center, Vardhman Mahavir Medical College & Safdarjung Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 21 papers. Top paper: “Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma”.

Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma

European Journal of Cancer(2020)10.1016/j.ejca.2019.12.006

N/A

1.3DataRank · unranked

29 citations

Fushen Sha, Anna Alperovich, Ai Ni, Katy Smith, Zhitao Ying +20 more

Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2183

N/A

0.850DataRank · unranked

22 citations

Laure Michaud, Karissa Whiting, Reiko Nakajima, Chelsea Nichols, Stephanie De Frank +19 more

Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation

Blood(2025)10.1182/blood.2024025563

N/A

0.596DataRank · unranked

52 citations

Jacob Soumerai, Jeremy S. Abramson, Jeffrey A. Barnes, Philip Caron, Shalini Chhabra +23 more

[18F]FDG-PET/CT Radiomics for Prediction of Bone Marrow Involvement in Mantle Cell Lymphoma: A Retrospective Study in 97 Patients

Cancers(2020)10.3390/cancers12051138

N/A

0.550DataRank · unranked

38 citations

Christopher C. Riedl, Anita Kumar, Ahmet Doǧan, Peter Gibbs, Michael Weber +4 more

TP53mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy

Blood Advances(2023)10.1182/bloodadvances.2023009953

N/A

0.505DataRank · unranked

28 citations

Nivetha Ganesan, Zachary D. Epstein‐Peterson, Alison J. Moskowitz, Robert Stuver, Catherine Maccaro +27 more

Hippocampal overexpression of NOS1AP promotes endophenotypes related to mental disorders

EBioMedicine(2021)10.1016/j.ebiom.2021.103565

N/A

0.442DataRank · unranked

18 citations

Esin Candemir, Xufeng Chen, Lili Li, Dilhan Esen-Sehir, Nicole Schenk +13 more

Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma

Blood Cancer Journal(2022)10.1038/s41408-022-00620-w

N/A

0.291DataRank · unranked

5 citations

Michelle Okwali, Anna Alperovich, Philip Caron, Lorenzo Falchi, Audrey Hamilton +22 more

Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma

Blood Advances(2025)10.1182/bloodadvances.2024014263

N/A

0.113DataRank · unranked

1 citations

Parastoo B. Dahi, Farhad Khimani, Andrei R. Shustov, Mazyar Shadman, Jia Ruan +19 more

Retrospective characterization of nodal marginal zone lymphoma

Blood Advances(2023)10.1182/bloodadvances.2022009587

N/A

0DataRank · unranked

8 citations

Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip Caron +24 more

Data from Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring

(2023)10.1158/1078-0432.c.6530889.v1

N/A

0DataRank · unranked

0 citations

Laure Michaud, Karissa Whiting, Reiko Nakajima, Chelsea Nichols, Stephanie De Frank +19 more

Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes

Blood Cancer Journal(2024)10.1038/s41408-024-01148-x

N/A

0DataRank · unranked

3 citations

Efrat Luttwak, Alfredo Rivas‐Delgado, Helen Irawan, Alexander P. Boardman, Philip Caron +26 more

CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas

Blood Neoplasia(2024)10.1016/j.bneo.2024.100031

N/A

0DataRank · unranked

1 citations

Kurt S. Bantilan, Erel Joffe, M. Lia Palomba, Ariela Noy, Philip Caron +12 more

Mutational and copy number analysis at diagnosis and relapse of mantle cell lymphoma

Haematologica(2025)10.3324/haematol.2024.286813

N/A

0DataRank · unranked

1 citations

Manik Uppal, Serena Zheng, Kurt S. Bantilan, Connie Lee Batlevi, Zachary D. Epstein‐Peterson +21 more

Long‐term outcomes of patients with limited‐stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era

British Journal of Haematology(2022)10.1111/bjh.18590

N/A

0DataRank · unranked

2 citations

Brandon S. Imber, Michelle Okwali, Paul A. Hamlin, Anita Kumar, Oscar Lahoud +11 more

Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms

Blood Advances(2020)10.1182/bloodadvances.2020001636

N/A

0DataRank · unranked

111 citations

Kseniya Petrova‐Drus, Sarah Huet, Zachary D. Epstein‐Peterson, Qi Gao, Allison E. Sigler +12 more

A phase I and randomized phase II etctn study of KW-0761 (Mogamulizumab) and MK-3475 (Pembrolizumab) in relapsed and refractory diffuse large B-cell lymphoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps8072

N/A

0DataRank · unranked

5 citations

Santosha A. Vardhana, Anita Kumar, Mehrdad Abedi, Rasmus T. Hoeg, Elad Sharon +2 more

CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer

Nature Medicine(2021)10.1038/s41591-021-01386-7

N/A

0DataRank · unranked

520 citations

Nicholas Han, Paul Wileyto, Justin Kim, Sigrid Gouma, James Robinson +55 more

A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma

Blood Advances(2022)10.1182/bloodadvances.2021006555

N/A

0DataRank · unranked

6 citations

Hiu Ying Lam, Karissa Whiting, Anita Kumar, Matthew J. Matasar, Colette Owens +10 more

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups

Blood Cancer Journal(2020)10.1038/s41408-020-00340-z

N/A

0DataRank · unranked

203 citations

Fushen Sha, Anna Alperovich, Ai Ni, Katy Smith, Zhitao Ying +20 more

A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma

Blood Advances(2023)10.1182/bloodadvances.2022008916

N/A

0DataRank · unranked

29 citations

Subir Goyal, Jeffrey M. Switchenko, Jason T. Romancik, Manali Kamdar, Irl Brian Greenwell +17 more

Clinical efficacy and safety of chimeric antigen receptor T‐cell therapy for mantle cell lymphoma with secondary central nervous system involvement

British Journal of Haematology(2023)10.1111/bjh.19037

N/A

0DataRank · unranked

16 citations

Rebecca L. Zon, Robert Redd, David C. Fisher, Roni Shouval, Anita Kumar +12 more